People In The News | GenomeWeb

NEW YORK (GenomeWeb News) – The genomics data analysis developer Bina Technologies said this week that it has added three executives to its management ranks, including Take Ogawa, Sharon Barr, and Tom Kanar.

Ogawa, who will be director of field sales, has held senior commercial positions at Complete Genomics, RainDance Technologies, Roche, and Invitrogen, now a Life Technologies business.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genome-wide transcriptome analysis of brain samples from people with autism spectrum disorder, flounder genome, and more.

Researchers used T-cell transfer therapy to target mutation KRAS, according to the New York Times.

The US Senate has passed the 21st Century Cures Act, which would provide a funding boost at NIH while overhauling FDA policies.

Bloomberg reports that President-elect Donald Trump is considering Jim O'Neill for Food and Drug Administration commissioner.